The Value Analysis of Conventional Drugs for Cerebrovascular Disease and SSRI Antidepressants in the Treatment of Post-stroke Depression

ZHANG Lijun; HUANG Yiping

doi:10.12102/j.issn.1672-1349.2020.03.035

Home>Articles>The Value Analysis of Conventional Drugs for Cerebrovascular Disease and SSRI Antidepressants in the Treatment of Post-stroke Depression

DOI: 10.12102/j.issn.1672-1349.2020.03.035

The Value Analysis of Conventional Drugs for Cerebrovascular Disease and SSRI Antidepressants in the Treatment of Post-stroke Depression

ZHANG Lijun

HUANG Yiping

Machine-generated Keywords：

Publication Date：2020-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 511-514 )

Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease

ISTIC

ISSN：1672-1349

Year, Vol.(Issue)：2020,18(3)